Abstract:Translational medicine is known as biomedicine models with purpose of finding solutions for clinical challenges. The clustered regularly interspaced short palindromic repeats associated protein 9 (CRISPR‐Cas9) system makes impressive strides therein through gene knockout, knock‐in, activation, interference, base editing, and sequence detection, and continues to revolutionize the development of translational medicine. Translational medicine aims to improve human health by exploring potential treatment methods developed during basic scientific research and applying them to the treatment of patients in clinical settings. The advanced perceptions of gene functions have remarkably revolutionized clinical treatment strategies for target agents. However, the progress in gene editing therapy has been hindered due to the severe off‐target effects and limited editing sites. Fortunately, the development in the clustered regularly interspaced short palindromic repeats associated protein 9 (CRISPR‐Cas9) system has renewed hope for gene therapy field. The CRISPR‐Cas9 system can fulfill various simple or complex purposes, including gene knockout, knock‐in, activation, interference, base editing, and sequence detection. Accordingly, the CRISPR‐Cas9 system is adaptable to translational medicine, which calls for the alteration of genomic sequences. This review aims to present the latest CRISPR‐Cas9 technology achievements and prospect to translational medicine advances. The principle and characterization of the CRISPR‐Cas9 system are firstly introduced. The authors then focus on recent pre‐clinical and clinical research directions, including the construction of disease models, disease‐related gene screening and regulation, and disease treatment and diagnosis for multiple refractory diseases. Finally, some clinical challenges including off‐target effects, in vivo vectors, and ethical problems, and future perspective are also discussed.

Cell Reprogramming With CRISPR/Cas9 Based Transcriptional Regulation Systems

Development and application of CRISPR/Cas9 technologies in genomic editing.

CRISPR/Cas9 Genome Editing: A Promising Tool For Therapeutic Applications of Induced Pluripotent Stem Cells.

CRISPR innovations in tissue engineering and gene editing

Expansion of the CRISPR/Cas Genome-Sculpting Toolbox: Innovations, Applications and Challenges

Next-generation CRISPR technology for genome, epigenome and mitochondrial editing

Recent Progress in CRISPR/Cas9 Technology

Advances in CRISPR-Cas systems for epigenetics

CRISPR-Cas Systems: Overview, Innovations and Applications in Human Disease Research and Gene Therapy

CRISPR-Cas systems for editing, regulating and targeting genomes

CRISPR/Cas9 Systems and Gene Editing Technology

CRISPR technologies for genome, epigenome and transcriptome editing

CRISPRs for Optimal Targeting: Delivery of CRISPR Components as DNA, RNA, and Protein into Cultured Cells and Single-Cell Embryos

Cas9-Based Tools For Targeted Genome Editing And Transcriptional Control

CRISPR-Cas System: The Current and Emerging Translational Landscape

Spatiotemporal control of CRISPR/Cas9 gene editing

CRISPR/Cas system: An emerging technology in stem cell research

Recent Research Trends in Stem Cells Using CRISPR/Cas-Based Genome Editing Methods

CRISPR/Cas9‐mediated genome editing: From basic research to translational medicine

Progress and Perspective of CRISPR‐Cas9 Technology in Translational Medicine

Evolution of CRISPR/Cas Systems for Precise Genome Editing